page_banner

Products

Rocuronium Bromide LK-8 CAS: 119302-24-8

Short Description:

Catalog Number: XD94110
Cas: 119302-24-8
Molecular Formula: C29H48N2O4
Molecular Weight: 488.7
Availability: In Stock 
Price:  
Prepack:  
Bulk Pack: Request Quote

Product Detail

Product Tags

Catalog Number XD94110
Product Name Rocuronium Bromide LK-8
CAS 119302-24-8
Molecular Formula C29H48N2O4
Molecular Weight 488.7
Storage Details Ambient

Product Specification

Appearance White powder
Assay 99% min

 

Rocuronium bromide (LK-8) is a neuromuscular blocking agent primarily used as part of general anesthesia to induce muscle relaxation and facilitate endotracheal intubation during surgeries. It belongs to the class of non-depolarizing neuromuscular blockers, specifically aminosteroids.When administered intravenously, rocuronium bromide acts by competitively binding to the nicotinic acetylcholine receptors at the neuromuscular junction, blocking the transmission of nerve impulses and inhibiting skeletal muscle contraction. This leads to muscle relaxation and paralysis, allowing for easier intubation and providing optimal surgical conditions.One of the primary advantages of rocuronium bromide is its rapid onset of action, typically taking effect within one to two minutes. This quick onset allows for rapid establishment of muscle relaxation, which is especially critical during emergency situations or when a rapid sequence induction method is required.Rocuronium bromide is also appreciated for its intermediate duration of action, typically ranging from 30 to 60 minutes. This duration allows for the maintenance of muscle relaxation throughout most surgical procedures, while shorter-acting agents like succinylcholine are used for shorter procedures.Importantly, because neuromuscular blockade can have adverse effects on respiratory function, it is crucial to carefully monitor patients receiving rocuronium bromide. Adequate artificial ventilation should be provided during the procedure to maintain adequate oxygenation and carbon dioxide elimination.Additionally, rocuronium bromide is primarily eliminated through hepatic metabolism and biliary excretion, making it suitable for use in patients with renal impairment or failure.While rocuronium bromide is primarily used during general anesthesia, it may also find applications in other medical settings where muscle relaxation is necessary. For example, it can be utilized in critical care units to sedate and facilitate mechanical ventilation in patients with acute respiratory distress syndrome.In conclusion, rocuronium bromide (LK-8) is a potent and effective neuromuscular blocking agent commonly used to induce muscle relaxation during general anesthesia. Its rapid onset and intermediate duration make it suitable for a wide range of surgical procedures. Careful monitoring and appropriate ventilation are essential to mitigate potential respiratory complications associated with its use.


  • Previous:
  • Next:

  • Close

    Rocuronium Bromide LK-8 CAS: 119302-24-8